Source: Axiogenesis Youtube Channel

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

25-100

Co-Founder & CEO

Heribert Bohlen

CEO Approval Rating

72/100

Axiogenesis engages in the development and commercialization of tissue-specific human cell types derived from induced pluripotent stem cells.

Axiogenesis posted a video "iPSC Platform Overview" on YOUTUBE